Eric Bernstein

743 total citations
8 papers, 82 citations indexed

About

Eric Bernstein is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pharmacology. According to data from OpenAlex, Eric Bernstein has authored 8 papers receiving a total of 82 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 2 papers in Pharmacology. Recurrent topics in Eric Bernstein's work include Lung Cancer Treatments and Mutations (3 papers), Inflammatory mediators and NSAID effects (2 papers) and Cancer therapeutics and mechanisms (1 paper). Eric Bernstein is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), Inflammatory mediators and NSAID effects (2 papers) and Cancer therapeutics and mechanisms (1 paper). Eric Bernstein collaborates with scholars based in United States, Australia and France. Eric Bernstein's co-authors include Nasser H. Hanna, Ginger L. Milne, Sara Zaknoen, Francis Burrows, Barbara J. Gitlitz, Edgardo S. Santos, Adam P. Dicker, Harvey B. Wolkov, Liang Cheng and Christopher J. Sweeney and has published in prestigious journals such as Journal of Clinical Oncology, The FASEB Journal and Annals of Surgical Oncology.

In The Last Decade

Eric Bernstein

8 papers receiving 82 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Bernstein United States 5 36 30 24 21 18 8 82
Núria Pedrola Spain 5 49 1.4× 29 1.0× 73 3.0× 51 2.4× 9 0.5× 5 145
S. Lindsey Davis United States 5 15 0.4× 45 1.5× 41 1.7× 15 0.7× 6 0.3× 8 95
Xiaolin Pang China 8 17 0.5× 61 2.0× 54 2.3× 13 0.6× 7 0.4× 16 148
Fabio Volterra United States 4 30 0.8× 48 1.6× 53 2.2× 14 0.7× 8 0.4× 8 109
Adem Albayrak United States 6 33 0.9× 66 2.2× 45 1.9× 33 1.6× 6 0.3× 7 129
P. Hill Australia 5 12 0.3× 46 1.5× 43 1.8× 43 2.0× 4 0.2× 7 103
Hayley Donnella United States 5 26 0.7× 33 1.1× 65 2.7× 11 0.5× 3 0.2× 6 112
Katarína Gyurászová Slovakia 5 26 0.7× 23 0.8× 56 2.3× 29 1.4× 5 0.3× 7 92
Elisabeth Strack Germany 5 24 0.7× 32 1.1× 60 2.5× 41 2.0× 12 0.7× 5 127
Monica Piedimonte Italy 5 17 0.5× 15 0.5× 46 1.9× 9 0.4× 7 0.4× 6 137

Countries citing papers authored by Eric Bernstein

Since Specialization
Citations

This map shows the geographic impact of Eric Bernstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Bernstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Bernstein more than expected).

Fields of papers citing papers by Eric Bernstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Bernstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Bernstein. The network helps show where Eric Bernstein may publish in the future.

Co-authorship network of co-authors of Eric Bernstein

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Bernstein. A scholar is included among the top collaborators of Eric Bernstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Bernstein. Eric Bernstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Bernstein, Eric, Zhaohao Liao, & Kenneth W. Witwer. (2019). Cytotoxicity of aqueous cigarette smoke extract is affected by properties of pipettes used to prepare the extract.. PubMed. 2019. 2 indexed citations
2.
Lewis, Jennifer A., W. Jeffrey Petty, James J. Urbanic, Eric Bernstein, & Tamjeed Ahmed. (2018). Cure of Oligometastatic Classic Biphasic Pulmonary Blastoma Using Aggressive Tri-modality Treatment: Case Series and Review of the Literature. Cureus. 10(11). e3586–e3586. 7 indexed citations
3.
Gitlitz, Barbara J., Eric Bernstein, Edgardo S. Santos, et al.. (2014). A Randomized, Placebo-Controlled, Multicenter, Biomarker-Selected, Phase 2 Study of Apricoxib in Combination with Erlotinib in Patients with Advanced Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 9(4). 577–582. 29 indexed citations
4.
Clément-Duchêne, Christelle, Ronald B. Natale, Thierry Jahan, et al.. (2012). A phase II study of enzastaurin in combination with erlotinib in patients with previously treated advanced non-small cell lung cancer. Lung Cancer. 78(1). 57–62. 11 indexed citations
5.
Gitlitz, Barbara J., Eric Bernstein, George P. Keogh, et al.. (2011). Apricot-l: Results of a biomarker-based phase II randomized placebo-controlled study of apricoxib in combination with erlotinib in non-small cell lung cancer (NSCLC) patients.. Journal of Clinical Oncology. 29(15_suppl). 7528–7528. 1 indexed citations
6.
Lowery, Lonnie, et al.. (2011). Large chronic protein intake does not affect markers of renal damage in healthy resistance trainers. The FASEB Journal. 25(S1). 1 indexed citations
7.
Okera, Meena, Eric Bernstein, Liang Cheng, et al.. (2010). Evaluation of nuclear factor κB and chemokine receptor CXCR4 co‐expression in patients with prostate cancer in the Radiation Therapy Oncology Group (RTOG) 8610. British Journal of Urology. 108(2b). E51–8. 17 indexed citations
8.
Bernstein, Eric, et al.. (2006). Chemotherapy and Radiotherapy in the Treatment of Resectable Non–Small-Cell Lung Cancer. Annals of Surgical Oncology. 13(3). 291–301. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026